Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$8.60
-0.23-2.6%
Last update: Oct 12, 3:59 PM
$8.86
0.030.34%
MapLight Therapeutics Inc (MPLT) Stock Price, Quote, News & History
MPLTNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of MapLight Therapeutics (NASDAQ:MPLT) through any online brokerage.
Other companies in MapLight Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
MapLight Therapeutics has a consensus price target of $32.45.
The stock price for MapLight Therapeutics (NASDAQ: MPLT) is $8.62 last updated October 12, 2026 at 3:59 PM EDT.
There are no upcoming dividends for MapLight Therapeutics.
MapLight Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for MapLight Therapeutics.
MapLight Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
